Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects

Phase 1 Completed 40 enrolled Kubota Vision Inc. Otsuka Pharmaceutical Co., Ltd. · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of repeated doses of a new investigational drug (ACU-4429) in healthy human subjects.

Timeline

Start: 2009-07
Primary completion: 2010-04
Completion: 2010-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Emixustat	Small molecule	—	Oral

Indications

No indication recorded.